Interstitial cystitis and related painful bladder syndromes: Pathophysiology

Chronic Abdominal and Visceral Pain: Theory and Practice

Volumn , Issue , 2006, Pages 495-520

  Yoshimura, Naoki ^a   Birder, Lori A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85122717115     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (229)

1. Parsons CL, Benson G, Childs SJ, et al. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993; 150:845-848.
2. Hanno PM, Landis JR, Matthews-Cook Y, et al. The Interstitial Cystitis Database Study Group: The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999; 161:553-557.
3. Bladder Research Progress Review Group: Overcoming Bladder Disease. A Strategic Plan for Research. Bethesda, Md, National Institute of Diabetes & Digestive & Kidney Diseases (National Institutes of Health), 2002, Chap 8.
4. Chancellor MB, Yoshimura N. Treatment of Interstitial Cystitis. Urology 2004; 63(3 suppl 1):85-92.
5. NIH Publication No. 02-3220; National Kidney and Urologic Diseases Information Clearinghouse. Interstitial Cystitis. Bethesda MD, National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health), 2002.
6. Sant GR, Theoharides TC. Interstitial cystitis. Curr Opin Urol 1999; 9:297-302.
7. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001; 57(Suppl 6A):47-55.
8. Lilly JD, Parsons CL. Bladder surface glycosaminoglycans is a human epithelial permeability factor. Surg Gynecol Obstet 1990; 171:493-496.
9. Buffington CAT, Woodworth BE. Excretion of fluorescein in the urine of women with interstitial cystitis. J Urol 1997; 158:786-789.
10. Holm-Bentzen M, Sondergaard I, Hald T. Urinary excretion of a metabolite of histamine (1,4-methyl-imidazole-acetic-acid) in painful bladder disease. Br J Urol 1987; 59:230-233.
11. Nickel JC, Downey J, Morales A, Emerson L. Clark J Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier. J Urol 1998; 160:612-614.
12. Hanno PM, Fritz RW, Mulholland SG, Wein AJ. Heparin - Examination of its antibacterial adsorption properties. Urology 1981; 28(3):273-276.
13. Hurst RE. Structure, function and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 1994; 12:3.
14. Grases F, Ferragut LG, Bosta-Bauza A. Study of the early stages of renal stone formation: Experimental model using urothelium of pig urinary bladder. Urol Res 1966; 24:305-311.
15. Niku SD, Stein PC, Scherz HC, Parsons CL. A new method for cytodestrution of bladder epithelium using protamine sulfate and urea. J Urology 1994; 152:1025-1028.
16. Lewis SA, Berg JR, Kleine TJ. Modulation of epithelial permeability by extracellular macromolecules. Physiological reviews 1995; 75(3):561-589.
17. Tzan CJ, Berg JR, Lewis SA. Effect of protamine sulfate on the permeability properties of the mammalian urinary bladder. J membrane Biology 1993; 133:227-242.
18. Tzan CJ, Berg JR, Lewis SA. Mammalian urinary bladder permeability is altered by cationic proteins: modulation by divalent cations. Am J Physiol (Cell Physiol) 1994; 267:C1013-C1026.
19. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 2004; 5:1-12.
20. Lewis SA. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am J Physiol 2000; 278:F867-F874.
21. Hicks M. The mammalian urinary bladder: an accommodating organ. Biol Rev 1975; 50:215-246.
22. Martin BF. Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter. J Anat 1972; 112:433-455.
23. Lavelle J, Meyers S, Ramage R, et al. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol 2002; 283:F242-F253.
24. Negrete HO, Lavelle J, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol 1996; 271:F886-F894.
25. Zeidel ML. Low permeabilities of apical membranes of barrier epithelia: what makes water-tight membranes water-tight? Am J Physiol 1996; 271:F243-F245.
26. Hu P, Meyers S, Liang FX, et al. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol 2002; 283:F1200-F1207.
27. Wu WR, Lin JH, Walz T, et al. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 1994; 269:13716-13724.
28. Acharya P, Beckel J, Ruiz WG, et al. Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. Am J Physiol 2004; 287:F305-F318.
29. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Progress Biophy Mol Biol 2003; 81:1-44.
30. Tammela T, Wein AJ, Monson FC, Levin RM. Urothelial permeability of the isolated whole bladder. Neurourol Urodyn 1993; 12:39-47.
31. Wang E, Lee JM, Johnson JP, Kleyman T, Bridges R, Apodaca G. Hydrostatic pressure-regulated ion transport in bladder uoepithelium. Am J Physiol 2003; 285:F651-F663.
32. Chopra B, Barrick SR, Meyers S, et al. Expression and function of bradykinin B1/B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 2005; 562:859-871.
33. Murray E, Malley SE, Qiao LY, Hu VY, Vizzard MA. Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder. J Urol 2004; 172:2434-2439.
34. Wolf-Johnston AS, Beckel JM, Barrick SR, Kanai AJ, de Groat WC, Birder L. Induction of urinary cystitis results in increased expression of nerve growth factor and its receptors. Soc Neurosci Abstr 2004; 27:742.16.
35. Birder L, Ruan HZ, Chopra B, et al. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol 2004; 287:F1084-F1091.
36. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001; 22:182-188.
37. Lee HY, Bardini M, Burnstock G. Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol 2000; 163:2002-2007.
38. Tempest HV, Dixon AK, Turner WH, Elneil S, Sellers LA, Ferguson DR. P2X and P2Y receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 2004; 93: 1344-1388.
39. Birder L, Apodaca G, de Groat WC, Kanai AJ. Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 1998; 275:F226-F229.
40. Birder L, Nealen ML, Kiss S, et al. Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 2002a; 22:8063-8070.
41. Beckel J, Birder L, Kiss S, et al. Expression of nicotinic acetylcholine receptors in rat urothelium. Soc Neurosci Abstr 25: 2002; 538:10.
42. Chess-Williams R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 2002; 22:133-145.
43. D'Andrea MR, Saban MR, Nguyen NB, Andrade-Gordon P, Saban R. Expression of proteaseactivated receptor-1, -2, -3 and -5 in control and experimentally inflamed mouse bladder. Am J Pathol 2003; 162:907-923.
44. Carattino MD, Sheng S, Kleyman TR. Mutations in the pore region modify epithelial sodium channel gating by shear stress. J Cell Biol 2005; 280:4393-4401.
45. Lewis SA, Clausen C, Wills NK. Transport-related modulation of the membrane properties of urinary bladder epithelium. Biochim Biophys Acta 1991; 1070:99-110.
46. Lewis SA, Hanrahan JW. Apical and basolateral membrane ionic channels in rabbit urinary bladder epithelium. Pflugers Arch 1985; 405:S83-S88.
47. Smith PR, Mackler SA, Weiser PC, et al. Expression and localization of epithelial sodium channel in mammalian urinary bladder. Am J Physiol 1998; 274:F91-F96.
48. Barrick SR, Lee H, Meyers S, et al. Expression and function of TRPV4 in urinary bladder urothelium. Soc Neurosci Abstr 26: 2003; 608:6.
49. Birder L, Kanai AJ, de Groat WC, et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98:13396-13401.
50. Birder L, Nakamura Y, Kiss S, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002b; 5:856-860.
51. Stein RJ, Santos S, Nagatomi J, et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 2004; 172:1175-1178.
52. Szallasi A. Vanilloid receptor ligands: hopes and realities for the future. Drugs Aging 2001; 18: 561-573.
53. Caterina MJ. The vanilloid receptor: a molecular gateway to the pain pathway. Ann Rev Neurosci 2001; 24:602-607.
54. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature 1997; 389:816-824.
55. Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 1999; 162:3-11.
56. Ghuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411:957-962.
57. Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol 2004; 500:231-241.
58. Alessandri-Haber N, Yeh JJ, et al. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 2003; 39:497-511.
59. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000; 103:525-535.
60. Chung MK, Lee H, Caterina MJ. Warm temperatures activate TRPV4 in mouse 308 Keratinocytes. J Biol Chem 2003; 278:32037-32046.
61. Tsavaler L, Shapero MH, Morkowski S, Laus R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res 2001; 61:3760-3769.
62. Birder L, Barrick SR, Roppolo JR, et al. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol 2003; 285:F423-F429.
63. Chess-Williams R. Potential therapeutic targets for the treatment of detrusor overactivity. Expert Opin Ther Targets 2004; 8:95-106.
64. Chopra B, de Groat WC, Roppolo JR, et al. Alterations in stretch mediated prostacyclin release from bladder urothelium in feline interstitial cystitis. The FASEB Journal 18: 2003; 399:10.
65. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J Physiol 1997; 505.2:503-511.
66. Beckel J, Barrick SR, Keast JR, et al. Expression and function of urothelial muscarinic receptors and interactions with bladder nerves. Soc Neurosci Abstr 26: 2004; 846:23.
67. Yiangou Y, Facer P, Ford A, Brady C, Wiseman O, Fowler CJ, Anand P. Capsaicin receptor VRI and ATP-gated ion channel P2x3 in human urinary bladder. BjU Int 2001; 87:774-779.
68. Cockayne DA, Hamilton SG, Zhu QM, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X(3)-deficient mice. Nature 2000; 407:1011-1015.
69. Homolya L, Steinberg TH, Boucher RC. Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 2000; 150:1349-1360.
70. Jallat-Daloz I, Cognard JL, Badet JM, Regnard J. Neural-epithelial cell interplay: in vitro evidence that vagal mediators increase PGE2 production by human nasal epithelial cells. Allergy Asthma Proc 2001; 22:17-23.
71. Wang EC, Lee JM, Ruiz WG, et al. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Investigation 2005 115:2412-2422.
72. Sun Y, Chai TC. Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 2004; 171:448-452.
73. Wolf-Johnston AS, Buffington CA, Roppolo JR, et al. Increased NGF and TRPV1 expression in urinary bladder and sensory neurons from cats with feline interstitial cystitis. Soc Neurosci Abst 2003; 27:608.4.
74. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activation by metabotropic ATP receptors: a possible mechanism for ATP-evoked pain and hypersensitivity. Proc Natl Acad Sci USA 2001; 29:820-825.
75. Gillenwater JY, Wein AJ. Summary of the national institute of arthritis, diabetes, and kidney diseases workshop on interstitial cystitis. J Urol 1998; 140:205.
76. Nickel JC. Interstitial cystitis-an elusive clinical target? J Urol 2003; 170:816-817.
77. Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998; 159:1862-1867.
78. Buffington CA, Chew DJ, Woodworth BE. Feline interstitial cystitis. J Am Vet Med Assoc 1999a; 215:682-687.
79. Buffington CA, Chew DJ, Woodworth BE. Interstitial cystitis in humans, and cats? Urology 1999b; 53:239-240.
80. Buffington CA. Visceral pain in humans: lessons from animals. Curr Pain Headache Rep 2001; 5:44-51.
81. Westropp J, Buffington CA. In vivo models of interstitial cystitis. J Urol 2002; 167:694-702.
82. Sun Y, Keay S, DeDeyne PG, Chai TC. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 2001; 166:1951-1956.
83. Roppolo JR, Tai C, Booth AM, Buffington CA, de Groat WC, Birder LA. Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis. J Urol 2005; 173:1011-1015.
84. Anderson G, Palermo J, Schilling J, Roth R, Heuser J, Hultgren S. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003; 301:105-107.
85. Birder L, Wolf-Johnston AS, Buffington CA, Roppolo JR, de Groat WC, Kanai AJ. Altered Inducible Nitric Oxide Synthase Expression and Nitric Oxide Production in Urinary Bladder from Cats with Feline Interstitial Cystitis. J Urol 2005; 173:625-629.
86. Lavelle J, Meyers SA, Ruiz WG, Buffington CA, Zeidel ML, Apodaca G. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol 2000; 278:F540-F553.
87. Truschel ST, Ruiz WG, Kanai AJ, et al. Involvement of nitric oxide (NO) in bladder afferent and urothelial abnormalities following chronic spinal cord injury. Soc Neurosci Abstr 2001; 24:842-849.
88. Han X, Fink MP, Uchiyama T, Yang R, Delude RL. Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol 2004; 286:L259-L267.
89. Keay S, Warren JW, Zhang CO, Tu LM, Gordon DA, Whitmore KE. Antiproliferative activity is present in bladder but not renal pelvic urine from interstitial cystitis patients. J Urol 1999; 162: 1487-1489.
90. Keay SK, Szekely Z, Conrads TP, et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 2004; 101:11803-11808.
91. Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor-which is the main mechanism of action? Eur Urol 2003; 43:1-5.
92. Kim JH, Rivas DA, Shenot PJ, et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med 2003; 26:358-363.
93. Szallasi A, Fowler CJ. After a decade of intravesical vanilloid therapy: still more questions than answers. Lancet Neurol 2002; 1:167-172.
94. Haarala M, Jalava J, Laato M, Kiilholma P, Nurmi M, et al: Absence of bacterial DNA in the bladder of patients with interstitial cystitis. J Urol 1996; 156:1843-1845.
95. Warren JW. Interstitial cystitis as an infectious disease. Urol Clin North Am 1994; 21:31-39.
96. Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 2002; 45:259-272.
97. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993; 73:229.
98. Lecci A, Maggi CA. Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 2001; 101:1.
99. Hohenfellner M, Nunues L, Schmidt RA, et al. Interstitial cystitis: Increased sympathetic innervation and related neuropeptide synthesis. J Urol 1992; 147:587-591.
100. Pang X, Marchand J, Sant GR, et al. Increased number of substance P positive fibers in interstitial cystitis. Br J Urol 1995; 75:744-750.
101. Chen Y, Varghese R, Chiu P, et al. Urinary substance P is elevated in women with interstitial cystitis. J Urol 1999; 161(4):26.
102. Theoharides TC, Sant GR. New agents for the medical treatment of interstitial cystitis. Exp Opin Invest Drugs 2001; 10:521-546.
103. Häbler HJ, Jänig W, Koltzenburg M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol (Lond) 1990; 425:545-562.
104. Sengupta JN, Gebhart GF. Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 1994; 72:2420-2430.
105. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288:1765-1769.
106. Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001; 8:1-10.
107. Yoshimura N, Seki S, Chancellor MB, de Groat WC, Ueda T. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology 2002; 59(5 suppl 1):61-67.
108. Janig W. Morrison JFB: Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res 1986; 67:87-114.
109. de Groat WC. Spinal interneurons and preganglionic neurons in sacral autonomic reflex pathways. In: The Emotional Motor System, Progress in Brain Research edited by Holstege G, Bandler R, Saper C. Amsterdam: Elsevier Science Publishers, 1995.
110. Morgan C, Nadelhaft I, de Groat WC. The distribution of visceral primary afferents from the pelvic nerve to Lissauer's tract and the spinal gray matter and its relationship to the sacral parasympathetic nucleus. J Comp Neurol 1981; 201:415-440.
111. Thor KB, Hisamitsu T, Roppolo JR, Tuttle P, Nagel J, de Groat WC. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat. J Pharmacol Exp Ther 1989; 248:1018-1025.
112. de Groat WC. Spinal cord projections and neuropeptides in visceral afferent neurons. Prog. Brain Res 1986; 67:165-187.
113. + channels in afferent neurones innervating rat urinary bladder following spinal cord injury. J Physiol 1997; 503:269-276.
114. de Groat WC, Nadelhaft I, Milne RJ, Booth AM, Morgan C, Thor K. Organization of the sacral parasympathetic reflex pathways to the urinary bladder large intestine. J Auton Nerv Syst 1981; 3:135-160.
115. Mallory B, Steers WD, de Groat WC. Electrophysiological study of micturition reflexes in rats. Am J Physiol 1989; 257:R410-R421.
116. Habler HJ, Janig JW, Koltzenburg M. Myelinated primary afferents of the sacral spinal cord responding to slow filling and distension of the cat urinary bladder. J Physiol 1993; 463:449.
117. McMahon SB, Abel C. A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain 1987; 28:109-127.
118. Fall M, Lindstrom S, Mazieres L. A bladder-to-bladder cooling reflex in the cat. J Physiol 1990; 427:281-300.
119. Maggi CA. The dual, sensory and efferent function of the capsaicin-sensitive primary sensory nerves in the bladder and urethra. 1 ed. In: Maggi CA, ed. Vol. 3. The Autonomic Nervous System. Nervous Control of the Urogenital System. London: Harwood Academic Publishers, 1993:383-422.
120. Wen J, Morrison JF. The effects of high urinary potassium concentration on pelvic nerve mechanoreceptors and silent afferents from the rat bladder. Adv Exp Med Biol 1995; 385:237-239.
121. Dmietrieva, N, McMahon, SB. Sensitization of visceral afferents by nerve growth factor in the adult rat. Pain 1996; 66:87-97.
122. de Groat WC, Kawatani M., Hisamitsu T, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; 30:S71-S78.
123. Maggi CA, Conte B. Effect of urethane anesthesia on the micturition reflex in capsaicin-treated rats. J Auton Nerv Syst 1990; 30:247-251.
124. Cheng C.L, Ma C.P, de Groat W.C. The effects of capsaicin on micturition and associated reflexes in the rat. Am J Physiol 1993; 265:R132-R648.
125. Morrison JF. The physiological mechanisms involved in bladder emptying. Scandinavian J Urology & Nephrology 1997; 184:15-18.
126. Yoshimura N, White G, Weight FF, de Groat WC. Patch-clamp recordings from subpopulations of autonomic and afferent neurons identified by axonal tracing techniques. J Auton Nerv Syst 1994; 49:86-92.
127. Yoshimura N, White G, Weight FF, de Groat WC. Different types of Na+ and K+ currents in rat dorsal root ganglion neurons innervating the urinary bladder. J Physiol 1996; 494:1-16.
128. Yoshimura N, de Groat WC. Neural control of lower urinary tract. Int J Urol 1997; 4:101-115.
129. 2+ channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol 2001b; 86:304-311.
130. Yoshimura N, Seki S, Erickson KA, Erickson VL, Chancellor MB, de Groat WC. Histological and electrical properties of rat dorsal root ganglion neurons innervating the lower urinary tract. J Neurosci 2003; 23:4355-4361.
131. Zhong Y, Banning AS, Cockayne DA, Ford AP, Burnstock G, McMahon SB. Bladder and cutaneous sensory neurons of the rat express different functional P2X receptors. Neuroscience 2003; 120: 667-675.
132. Dang K, Bielefeldt K, Gebhart GF. Differential responses of bladder lumbosacral and thoracolumbar dorsal root ganglion neurons to purinergic agonists, protons, and capsaicin. J Neurosci 2005; 25(15):3973-3984.
133. Yoshimura N, de Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder following chronic bladder inflammation. J Neurosci 1999; 19:4644-4653.
134. Waddell PJ, Lawson SN. Electrophysiological properties of subpopulations of rat dorsal root ganglion neurons in vitro. Neuroscience 1990; 36:811-822.
135. Gold MS, Dastmalchi S, Levine JD. Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro. Neuroscience 1996b; 71:265-275.
136. 4 receptors couple positively to tetrodotoxininsensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons. J Neurosci 1997; 17:7181-7189.
137. Yoshimura N, Seki S, Novakovic SD, et al. The involvement of the tetradotoxin-resistant sodium channel Nav1.8 (PN3/SNS) in a rat model of visceral pain. J Neurosci 2001a; 21:8690-8696.
138. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996; 379:257-262.
139. Sangameswaran L, Delgado SG, Fish LM, et al. Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 1996; 271:5953-5956.
140. Novakovic SD, Tzoumaka E, McGivern JG, et al. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 1998; 18:2174-2187.
141. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci USA 1998; 95:8963-8968.
142. Tate S, Benn S, Hick C, Trozise D, John V. et al. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nat Neurosci. 1998 1:653-655.
143. Black JA, Cummins TR, Yoshimura N, de Groat WC, Waxman SG. Tetrodotoxin resistant sodium channels Na(V) 1.8 / SNS and NA(V) 1.9 / NAN in afferent neurons innervating urinary bladder in control and spinal cord injured rats. Brain Res 2003; 963:132-138.
144. Fjell J, Cummins TR, Dib-Hajj SD, Fried K, Black JA, Waxman SG. Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons. Mol Brain Res 1999; 67:267-282.
145. Fjell J, Hjelmstrom P, Hormuzdiar W, et al. Localization of the tetrodotoxin-resistant sodium channel NaN in nociceptors. Neuroreport 2000; 11:199-202.
146. Bennett DL, Dmietrieva N, Priestley JV, Clary D, McMahon SB. trkA, CGRP and IB4 expression in retrogradely labelled cutaneous visceral primary sensory neurones in the rat. Neurosci Lett 1996; 206:33-36.
147. McFarlane S, Cooper E. Kinetics and voltage dependence of A-type currents on neonatal rat sensory neurons. J Neurophysiol 1991; 66:1380-1391.
148. Akins PT, McCleskey EW. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 1993; 56:759-769.
149. + currents in adult rat sensory neurons. J. Neurophysiol 1996a; 75:2629-2646.
150. 2+ channels and their role in neurotransmitter release. Cell Calcium 1998; 24:307-323.
151. Waterman SA. Voltage gated calcium channels in autonomic neuroeffector transmission. Prog Neurobiol 2000; 60:181-210.
152. 2+ channels in DRG neurons of the adult rat. J Neurophysiol 2003; 90:21-31.
153. Morrison J, Wen J, Kibble A. Activation of pelvic afferent nerves from the rat bladder during filling. Scand J Urol Nephrol 1999; 201(suppl):73-75.
154. Hoffman PN, Griffin JW, Price DL. Control of axonal caliber by neurofilament transport. J Cell Biol 1984; 99:705-714.
155. Hoffman PN, Cleveland DW, Griffin JW, Landes PW, Cowan, NJ, Price DL. Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci USA 1987; 84:3472-3476.
156. Lawson SN, Perry MJ, Prabhakar E, McCarthy PW. Primary sensory neurones: neurofilament, neuropeptides, and conduction velocity. Brain Res Bull 1993; 30:239-243.
157. Yoshimura N, Erdman SL, Snider MW, de Groat WC. Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience 1998; 83:633-643.
158. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines neuropeptides, adenosine triphosphate, amine acids and nitric oxide. Pharmacol Rev 1996; 48:113-178.
159. Hulsebosch CE, Coggeshall RE. An analysis of the axon populations in the nerves to the viscera in the rat. J Comp Neurol 1982; 211:1-10.
160. Vera PL, Nadelhaft I. Conduction velocity distribution of afferent fibers innervating the rat urinary bladder. Brain Res 1990; 520:83-89.
161. Keast JR, de Groat WC. Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J Comp Neurol 1992; 319:615-623.
162. Vizzard MA. Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis. J Comp Neurol 2000a; 420:335-348.
163. Steers WD, Mackway AM, Ciambotti J, de Groat WC. Alterations in neural pathways to the urinary bladder of the rat in response to streptozotocin-induced diabetes. J Auton Nerv Syst 1994; 47:83-94.
164. Avelino A, Cruz C, Nagy I, Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002; 109:787-798.
165. Rong W, Spyer KM, Burnstock G. Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol 2002; 541:591-600.
166. Studeny S, Torabi A, Vizzard MA. P2X2 and P2X3 Receptor expression in postnatal and adult rat urinary bladder and lumbosacral spinal cord. Am J Physiol Regul Integr Comp Physiol 2005 289:R1158-R1160.
167. Nishiguchi J, Hayashi Y, Chancellor MB, et al. Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate (ATP) under different delivery conditions in rats. Urology 2005 66:1332-1337.
168. Averill, S, McMahon, SB, Clary DO, Reichardt LF, Priestley JV. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci 1995; 7:1484-1494.
169. Bennett DL, Michael GJ, Ramachandran N, et al. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 1998; 18:3059-3072.
170. Snider WD, McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 1998; 20:629-632.
171. Kitchener PD, Wilson P, Snow PJ. Selective labelling of primary sensory afferent terminals in lamina II of the dorsal horn by injection of Bandeiraea simplicifolia isolectin B4 into peripheral nerves. Neuroscience 1993; 54:545-551.
172. Vulchanova L, Riedl MS, Shuster SJ, et al. P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci 1998; 10:3470-3478.
173. Guo A, Vulchanova L, Wang J, Li X, Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 1999; 11:946-958.
174. Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21:531-543.
175. Bennett DL, Dmietrieva N, Priestley JV, Clary D, McMahon SB. trkA, CGRP and IB4 expression in retrogradely labelled cutaneous visceral primary sensory neurones in the rat. Neurosci Lett 1996; 206:33-36.
176. Nishiguchi J, Sasaki K, Seki S, et al. Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci 2004; 20:474-482.
177. Seki S, Erickson KA, Seki M, et al. Elimination of rat spinal neurons expressing neurokinin 1 receptors reduces bladder overactivity and spinal c-fos expression induced by bladder irritation. Am J Physiol Renal Physiol 2005; 288:F466-F473.
178. Johansson SL, Ogawa K, Fall M. The pathology of interstitial cystitis. In: Sant GR, ed. Interstitial Cystitis. Philadelphia: Lippincott-Raven, 1997:143-151.
179. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001; 57(suppl 6A):47-55.
180. Dmitrieva N, Shelton D, Rice ASC, et al. The role of nerve growth factor in a model of visceral inflammation. Neuroscience 1997; 78:449-459.
181. England S, Bevan S, Docherty RJ. PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 1996; 495:429-440.
182. + current in nociceptors. Proc Natl Acad Sci U S A 1996; 93:1108-1112.
183. Cox PJ. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Pharmacol 1979; 28:2045-2049.
184. Lanteri-Minet M, Bon K, de Pommery J, et al. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 1995; 105:220-232.
185. Dang K, Bielefeldt K, Gebhart GF. Gastric ulcers reduce A-type potassium currents in rat gastric sensory ganglion neurons. Am J Physiol Gastrointest Liver Physiol 2004; 286:G573-G579.
186. Stewart T, Beyak MJ, Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol 2003; 552:797-807.
187. Sculptoreanu A, de Groat WC, Buffington CA, Birder LA. Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol 2005a; 193:437-443.
188. Lazzeri M, Beneforti P, Benaim G, Maggi CA, Lecci A, Turini D. Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. J Urol 1996; 156:947-952.
189. Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 2000; 164:676-679.
190. Payne CK, Mosbaugh PG, Forrest JB, et al. ICOS RTX Study Group (Resiniferatoxin Treatment for Interstitial Cystitis). Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 2005; 173(5):1590-1594.
191. Sculptoreanu A, de Groat WC, Buffington CA, Birder LA. Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis. Neurosci Lett 2005b; 381:42-46.
192. Dinis P, Charrua A, Avelino A, et al. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci 2004; 24:11253-11263.
193. Sugaya K, Nishijima S, Yamada T, Miyazato M, Hatano T, Ogawa Y. Molecular analysis of adrener-gic receptor genes and interleukin-4/interleukin-4 receptor genes in patients with interstitial cystitis. J Urol 2002; 168(6):2668-2671.
194. Vizzard MA, Erdman SL, de Groat WC. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol 1996; 370:191-202.
195. Vizzard MA, Boyle MM. Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis. Brain Res 1999; 844:174-187.
196. Vizzard MA. Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis. J Chem Neuroanat 2001; 21:125-138.
197. Dattilio A, Vizzard MA. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. J Urol 2005; 173(2):635-639.
198. Hu VY, Malley S, Dattilio A, Folsom JB, Zvara P, Vizzard MA. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am J Physiol Regul Integr Comp Physiol 2003; 284:R574-R585.
199. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A 1999; 96:7687-7692.
200. Cruz CD, Avelino A, McMahon SB, Cruz F. Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation. Eur J Neurosci 2005; 21(3):773-781.
201. Vizzard MA. Alterations in spinal cord Fos protein expression induced by bladder stimulation following cystitis. Am J Physiol Regul Integr Comp Physiol 2000b; 278:R1027-R1039.
202. Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 1999; 57:583-606.
203. Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 2000c; 161:273-284.
204. Steers WD, Kolbeck S, Creedon D, Tuttle JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991; 88:1709-1715.
205. Steers WD, Creedon DJ, Tuttle JB. Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J Urol 1996; 155:379-385.
206. Steers WD, Tuttle JB. Neurogenic inflammation and nerve growth factor: possible roles in interstitial cystitis. In: Sant GR, ed. Interstitial cystitis. Philadelphia: Lippincott-Raven, 1997:67-75.
207. Nilsson G, Forsberg-Nilsson, Xiang Z, et al. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997; 27:2295-2930.
208. Okragly AJ, Niles AL, Saban R, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 1999; 161:438-441.
209. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997; 79:572-577.
210. Qiao LY, Vizzard MA. Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol 2002; 454:200-211.
211. Qiao LY, Vizzard MA. Up-regulation of phosphorylated CREB but not c-Jun in bladder afferent neurons in dorsal root ganglia after cystitis. J Comp Neurol 2004; 469:262-274.
212. Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 2001; 165:975-979.
213. Seki S, Sasaki K, Igawa Y, et al. Detrusor overactivity induced by increased levels of nerve growth factor in bladder afferent pathways in rats. Neurourology and Urodynamics 2003; 22: 375-377.
214. Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder over-activity. J Pain 2004; 5:150-156.
215. Jaggar SI, Scott HC, Rice AS. Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent. Br J Anaesth 1999; 83: 442-448.
216. Hu VY, Zvara P, Dattilio A, et al. Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis. J Urol 2005; 173:1016-1021.
217. Ueda T, Tamaki M, Ogawa O, Yoshimura N. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J Urol 2002; 167:347-351.
218. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties protein interactions role in physiological processes. Physiol Rev 1991; 71:481.
219. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995; 128:687.
220. Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T. Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. J Urol 2004; 172:945-948.
221. van de Merwe JP, Yamada T, Sakamoto Y. Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int J Urol 2003; 10(suppl):S35-S38.
222. Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J Urol 2000; 164:1917-1920.
223. Moran PA, Dwyer PL, Carey MP, Maher CF, Radford NJ. Oral methotexate in the management of refractory interstitial cystitis. Aust N Z Obstet 1999; 39:468-471.
224. Silk MR. Bladder antibodies in interstitial cystitis. J Urol 1970; 103:307-309.
225. Jokinen E, Alfthan S, Oravisto K. Antitissue autoantibodies in interstitial cystitis. Clin Exp Immunol 1972; 11:333-339.
226. Anderson JB, Parivar F, Lee G, et al. The enigma of interstitial cystitis- An autoimmune disease? Br J Urol 1989; 63:58-63.
227. Warren JW, Jackson TL, Langenberg P, Meyers DJ, Xu J. Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology 2004; 63:17-21.
228. Weissman MM, Gross R, Fyer A, Heiman GA, et al. Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry. 2004; 61(3):273-279.
229. Malley SE, Vizzard MA. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiol Genomics 2002; 9:5-13.